EUVIMEDEUVIMED entdecken
Crossref

Infection of RAW 264.7 Cells by Murine Leukemia Virus‐Derived Retroviral Pseudotype Expressing the Envelope Glycoprotein of EBOV Is Enhanced by Antibodies

Chaldam Jespère Mbani iD, Famara Sane, Magloire Pandoua Nekoua iD, Corentin Morvan iD, Laurent Bellanger, Cyril Debuysschere iD, Delphine Lobert, Stéphanie Flament, Fabrice Bray, Christian Rolando, Maria Wurm, Divor Kiseljak und 6 weitere

Journal of Medical Virology · 2025

DOI: 10.1002/jmv.70702 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Virology, 2025. Verfasst von Chaldam Jespère Mbani und 17 weiteren Autor:innen. Beteiligte Einrichtung: Laboratoire de Virologie ULR3610, Université de Lille, CHU Lille, Lille, France. Hauptthemen laut MEDLINE: Viral Envelope Proteins, Antibodies, Viral, Leukemia Virus, Murine, Ebolavirus. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: The present work has been funded within the IMI-funded PEVIA project (project ID 116088) H2020..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

It has been shown that antibodies can enhance Ebola virus (EBOV) infection at sub‐neutralizing concentrations. The effect of antibodies on the infection of murine cell line (RAW 264.7) with MLV‐EBOV, a murine leukemia virus pseudotype expressing surface glycoprotein (GP) of EBOV and green fluorescent protein (GFP) has been studied. Moreover, regions of EBOV GP targeted by antibodies enhancing the infection have been investigated. Serum and monoclonal antibodies (mAbs) were obtained from mice inoculated with MLV‐EBOV. Plasma from patients and humanized anti‐EBOV GP mAbs were obtained. The proportion of GFP‐positive cells was determined by FACS analysis. Trypsin‐digested EBOV GP was incubated in affinity columns prepared with mAbs. Eluted peptides were analyzed by high‐resolution mass spectrometry. The infection of cells with MLV‐EBOV was enhanced by immune mouse serum, human plasma and mAbs. The infection was the result of interactions between MLV‐EBOV/antibody complexes and FcγRs. Regions of EBOV GP, located in GP1 core, furin cleavage site, N‐terminal part of GP2, and HR1 and HR2 domains are target of antibodies able to enhance the infection. In conclusion, the RAW 264.7 cell line associated with MLV‐EBOV can be used to study the enhancing activity of murine and human antibodies and may help to select antibodies or vaccine formulations that do not lead to enhancement of EBOV infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Viral Envelope ProteinsAntibodies, ViralLeukemia Virus, MurineEbolavirusAntibody-Dependent EnhancementAnimalsMiceHumansRAW 264.7 CellsAntibodies, MonoclonalAntibodies, Neutralizing

Substanzen

Viral Envelope ProteinsAntibodies, ViralAntibodies, MonoclonalAntibodies, Neutralizing

Autor:innen und Institutionen

  • Laboratoire de Virologie ULR3610, Université de Lille, CHU Lille, Lille, France.
  • Laboratoire de Biologie Cellulaire et Moléculaire, Faculté des Sciences et Techniques, Université Marien Ngouabi, Brazzaville, Congo.
  • Département Médicaments et Technologies pour la Santé (DMTS), SPI, CEA, INRAE, Université Paris-Saclay, Bagnols-sur-Cèze, France.
  • UAR 3290 - MSAP - Miniaturisation pour la Synthèse, l'Analyse et la Protéomique, CNRS, University of Lille, Lille, France.
  • ExcellGene, Monthey, Switzerland.
  • Virology Unit, National Institute for Infectious Disease "Lazzaro Spallanzani", IRCCS, Rome, Italy.

ORCID-Profile: Chaldam Jespère Mbani, Magloire Pandoua Nekoua, Corentin Morvan, Cyril Debuysschere, Enagnon Kazali Alidjinou, Didier Hober

Förderung

  • The present work has been funded within the IMI-funded PEVIA project (project ID 116088) H2020.

Zitieren

APA

Mbani, C. J., Sane, F., Nekoua, M. P., Morvan, C., Bellanger, L., Debuysschere, C., Lobert, D., Flament, S., Bray, F., Rolando, C., Wurm, M., Kiseljak, D., Colavita, F., Castilletti, C., Capobianchi, M. R., Alidjinou, E. K., Moukassa, D., & Hober, D. (2025). Infection of RAW 264.7 Cells by Murine Leukemia Virus‐Derived Retroviral Pseudotype Expressing the Envelope Glycoprotein of EBOV Is Enhanced by Antibodies. Journal of Medical Virology. https://doi.org/10.1002/jmv.70702

Vancouver

Mbani CJ, Sane F, Nekoua MP, Morvan C, Bellanger L, Debuysschere C, et al. Infection of RAW 264.7 Cells by Murine Leukemia Virus‐Derived Retroviral Pseudotype Expressing the Envelope Glycoprotein of EBOV Is Enhanced by Antibodies. Journal of Medical Virology. 2025. doi:10.1002/jmv.70702

BibTeX
@article{Mbani2025,
  author = {Mbani, Chaldam Jespère and Sane, Famara and Nekoua, Magloire Pandoua and Morvan, Corentin and Bellanger, Laurent and Debuysschere, Cyril and Lobert, Delphine and Flament, Stéphanie and Bray, Fabrice and Rolando, Christian and Wurm, Maria and Kiseljak, Divor and Colavita, Francesca and Castilletti, Concetta and Capobianchi, Maria Rosaria and Alidjinou, Enagnon Kazali and Moukassa, Donatien and Hober, Didier},
  title = {Infection of RAW 264.7 Cells by Murine Leukemia Virus‐Derived Retroviral Pseudotype Expressing the Envelope Glycoprotein of EBOV Is Enhanced by Antibodies},
  journal = {Journal of Medical Virology},
  year = {2025},
  doi = {10.1002/jmv.70702}
}
Kostenlos starten →